Building Your Own Pharmacology Tracker
I spent way too long trying to find a tool that handled half-life calculations, CYP450 interactions, and dosing schedules in one place. Every app I found was either built for clinicians with way more features than I needed or it was a glorified spreadsheet with no real computational power. So I built one. The core idea is simple: you feed it drug profiles, you run dose simulations, you check for interactions. But the devil is in the data, and that is where most DIY trackers fail before they even get started.
The Database Problem
Most people skip the hardest part and go straight to coding. A Diy Pharmacology Tracker is only as good as its underlying data, and getting reliable pharmacokinetic parameters is not easy. Half-lives, clearance rates, volume of distribution, protein binding percentages — these numbers vary by source, and they vary by patient population. I pulled my initial dataset from Micromedex and the FDA label database, then cross-referenced with Goodman and Gilman for anything that looked off. One thing I found that most guides miss: the half-life values listed in drug compendia are typically for healthy adults with normal renal and hepatic function. If your tracker is going to be used for patients with renal impairment, you need to build in clearance adjustment factors. I did this by implementing the Cockcroft-Gault equation for creatinine clearance estimation and scaling drug elimination accordingly. That single addition probably saved me from recommending doses that would have accumulated to toxic levels in a real scenario.
Interaction Checking Logic
CYP450 inhibition and induction is the bread and butter of pharmacology tracking, but it is also where oversimplification does the most damage. A lot of beginner trackers just flag any combination of two CYP3A4 substrates as an interaction. That is noise. What you actually need to model is competitive inhibition kinetics. I implemented a basic mechanism-based approach using the relationship between inhibitor concentration and the fraction of unmetabolized drug. The equation is straightforward: if you know the Ki value for a drug-drug interaction pair and the steady-state concentration of the inhibitor, you can estimate how much the clearance of the substrate drops. This gave me something far more useful than a binary yes-or-no flag. The limitation here is that most Ki values are in vitro measurements. They do not always translate cleanly to in vivo situations. I learned this the hard way when my tracker predicted a massive interaction between clarithromycin and simvastatin that was roughly double what the clinical literature reported. The workaround was to cap the predicted interaction magnitude at clinically observed values wherever I could find them. I built a lookup table of known interaction strengths from published case studies and used those as reality checks against the calculated predictions.
Get the Full Details
The Spreadsheet Trackers Everyone Tries First
Before I built the custom solution, I ran a Google Sheets version for about three months. It tracked doses, timers, and basic interaction flags. It worked until it did not. The moment I needed to run a loading dose calculation with renal adjustment, the spreadsheet became a maze of nested IF statements and broken links. I lost a week of work when someone accidentally overwrote a cell reference. That is when I moved to a proper application. Python with a SQLite backend handled the complexity without the fragility. The interaction database grew to about 800 drugs with roughly 3,200 documented interaction pairs. Not comprehensive, but enough to catch the vast majority of clinically relevant combinations in an outpatient setting.
What This Tracker Actually Does
Input a drug or medication list. The system pulls pharmacokinetic parameters, calculates steady-state concentrations based on the dosing schedule you enter, flags CYP-mediated interactions, and estimates dose adjustments for renal or hepatic impairment. It also tracks accumulated doses over time so you can see whether a regimen is approaching toxic thresholds. One feature that took me longer to get right than anything else was the therapeutic drug monitoring module. If you enter a measured serum concentration, the tracker uses Bayesian forecasting to refine the individual pharmacokinetic estimates. Most free tools skip this entirely. The reason is that Bayesian updating requires prior distributions for clearance and volume of distribution, and finding reliable population priors for common drugs took me weeks of literature digging. I ended up compiling priors from published population pharmacokinetic studies for about 120 drugs. Enough for practical use, not enough for anything exotic.
Common Pitfalls
Data entry errors are the biggest threat to accuracy. I had a user enter 500 mg instead of 50 mg for a vancomycin dose and the tracker confidently generated a pharmacokinetic profile that looked perfectly normal. The math was correct. The input was wrong. I added a range validation layer after that — any dose outside the typical therapeutic range triggers a confirmation prompt. It is a small thing but it caught several mistakes before they propagated through the system. Another issue is drug formulation differences. The pharmacokinetic parameters for immediate release and extended release formulations are not interchangeable, and a lot of open-source trackers treat them as the same compound. I made it mandatory to select the formulation type for each entry. It adds a step but it prevents garbage results from sneaking in.
Where It Falls Short
This tracker does not handle pharmacodynamics well. It models concentration over time but does not predict clinical effect. If two drugs both lower potassium, the tracker will not flag the additive hypokalemia risk unless you explicitly code that interaction. General drug-drug interaction databases like Lexicomp or Micromedex do this kind of broad-spectrum safety checking, and they have teams of pharmacologists validating entries. A DIY system built by one person cannot match that. It also does not account for genetic polymorphisms. CYP2D6 ultrarapid metabolizers will process drugs like codeine very differently than poor metabolizers, and the tracker has no way to model that. I considered adding a genotyping module but the clinical utility is too narrow for the development effort required. If you need that level of precision, commercial pharmacogenomics platforms are the better path. Finally, the interaction database is finite. New drugs come out constantly, and new interaction data gets published regularly. I update the database quarterly by pulling from PubMed and the FDA safety announcements, but there is always a lag between when an interaction becomes clinically recognized and when it appears in my tracker.
Getting Started If You Want to Build One
You do not need to start from scratch. There are a few open-source frameworks that handle the database schema and basic calculation engine. The one I modified was a Python package called pklib, which provides pharmacokinetic simulation functions out of the box. The problem was that it was not designed for drug interaction modeling, so I spent about two months writing the interaction checking module myself. If you are building this for personal use, start small. Pick twenty drugs you encounter frequently, get their full PK parameters, and build the interaction checker around those first. Do not try to populate the entire database upfront. That is the point where motivation dies and half-finished projects accumulate. The codebase I settled on is publicly available, but I would recommend forking it rather than using it directly because the interaction logic I wrote is specific to my data sources and clinical priorities. You will need to adapt it to whatever drugs and interaction types matter for your use case. The core structure is there, but the specifics are not transferable without modification.
The whole process from conception to a working system took me roughly four months working evenings and weekends. The first version was fragile and had more gaps than features. The current version handles maybe sixty percent of the scenarios I care about, and I am still adding to it. That is probably the most honest thing I can say about building a Diy Pharmacology Tracker: it is never done, and that is the point.
